Benefits
Pregnancy nausea (NVP) — strongest evidence
Across multiple RCTs, ginger significantly improved pregnancy-related nausea without significantly reducing vomiting episodes. ACOG and the Society of Obstetricians and Gynaecologists of Canada include it as a first-line non-pharmacologic option; lower doses (<1,500 mg/day) appear favored. Strongest evidence base for any ginger use.
Chemotherapy and postoperative nausea
Multiple RCTs and an umbrella review confirm ginger reduces chemotherapy-induced nausea and vomiting and postoperative nausea, decreasing the need for rescue antiemetics. The effect is modest in magnitude but consistent. A reasonable adjunct to standard antiemetic regimens, not a replacement.
Osteoarthritis pain — modest effect
Meta-analysis of placebo-controlled RCTs in osteoarthritis patients found ginger modestly efficacious for pain and physical function (a small standardized effect, pain SMD about -0.30), though the ginger group was about twice as likely to discontinue (RR 2.33). Not validated head-to-head against NSAIDs at scale.
Exercise-induced muscle pain (DOMS)
RCTs show 1-2 g/day raw or heat-treated ginger reduces eccentric-exercise-induced muscle pain by roughly 25-30% and improves pain-pressure threshold. Effects are most pronounced with 1-2 weeks of pre-loading before unaccustomed exercise. Mechanism: COX-2 and prostaglandin E2 inhibition.
Blood sugar — mixed evidence
Some meta-analyses show significant fasting glucose and HbA1c reductions in type 2 diabetes, while other RCT reviews (1.2-2 g/day) found no significant effect. The benefit appears dose-dependent, with larger doses (>2 g/day) in the positive trials. Mechanism: 6-gingerol activates PPAR-γ and inhibits alpha-glucosidase.
Anti-inflammatory and lipid effects
Multiple meta-analyses show ginger supplementation reduces CRP, IL-6, TNF-α, total cholesterol, LDL, and triglycerides — particularly in metabolic syndrome and inflammatory conditions. Effects are modest but consistent. Mechanism: dual COX-1/2 and 5-LOX inhibition (different from NSAIDs which only target COX), plus NF-κB pathway suppression and antioxidant activity.
Digestive health and motility
Ginger accelerates gastric emptying, reduces bloating, and improves GI motility — useful for functional dyspepsia, gastroparesis, and general digestive discomfort. Mechanism: 5-HT3 and 5-HT4 receptor modulation plus cholinergic enhancement. This same prokinetic activity is mechanistically linked to the anti-nausea effect (gastric stasis is a key trigger of nausea).
Dysmenorrhea (menstrual pain)
Multiple RCTs show 750-2,000 mg ginger over the first 3 days of menstruation reduces pain severity comparable to mefenamic acid and ibuprofen in young women. Mechanism: prostaglandin synthesis inhibition, the same target as NSAID-class menstrual pain relief. A reasonable first-line option for those preferring botanical alternatives.
Mechanism of action
Dual COX and 5-LOX inhibition
Gingerols and shogaols inhibit cyclooxygenase-1 and -2 (COX-1/2) reducing prostaglandin synthesis, and simultaneously inhibit 5-lipoxygenase (5-LOX) reducing leukotriene production. This dual pathway inhibition provides broader anti-inflammatory coverage than NSAIDs (COX-only) or Boswellia (5-LOX-only) individually.
5-HT3 receptor antagonism for anti-nausea effects
6-gingerol and 6-shogaol antagonize 5-HT3 (serotonin type 3) receptors in the GI tract and vomiting center — the same receptor blocked by ondansetron (Zofran), a leading antiemetic drug. This mechanism produces ginger's rapid anti-nausea effects without the adverse effects of pharmaceutical 5-HT3 antagonists.
PPAR-γ activation and insulin sensitization
6-gingerol activates peroxisome proliferator-activated receptor gamma (PPAR-γ), improving adipocyte differentiation, adiponectin secretion, and peripheral insulin sensitivity. This nuclear receptor mechanism explains ginger's metabolic benefits for blood sugar control and body composition beyond its anti-inflammatory activity.
Clinical trials
12 clinical trials in 1,278 pregnant women.
1,278 pregnant women
12 clinical trials in 1,278 pregnant women. Ginger significantly improved nausea symptoms (MD 1.20, 95% CI 0.56-1.84, p=0.0002, I²=0%). Vomiting reduction trended toward significance (MD 0.72, 95% CI -0.03-1.46, p=0.06). Subgroup analyses favored daily doses <1,500 mg. Foundation for current obstetric guideline inclusion.
5 placebo-controlled clinical trials, 593 OA patients (mainly knee/hip).
593 patients across pooled studies
5 placebo-controlled clinical trials, 593 OA patients (mainly knee/hip). Ginger was 'modestly efficacious' for pain (Hedges' SMD favoring ginger) and physical function. Adverse events were mild and reversible. Authors' caveat: ginger group was 2× as likely to discontinue treatment vs. placebo group, mostly due to GI tolerability. Evidence quality judged moderate (small samples, ITT issues).
10 clinical trials, 490 T2D patients.
10 clinical trials pooled
10 clinical trials, 490 T2D patients. Significant reduction in HbA1c (WMD -1.00%, 95% CI -1.56 to -0.44, p<0.001) and fasting glucose (WMD -21.24 mg/dL, p<0.001). Note: a 2024 Clinical Nutrition ESPEN review of 5 lower-dose clinical trials (1.2-2 g/day, 4-12 weeks) found NO significant effect — suggesting effect may be dose-dependent.
32 distance runners, 1.425 g/day ginger × 5 days before downhill running protocol.
Clinical population described in trial publication.
32 distance runners, 1.425 g/day ginger × 5 days before a downhill running protocol (Wilson 2020). Ginger possibly produced a moderate reduction in running-induced muscle soreness, but effects on physical performance recovery were likely negligible. Builds on earlier work (Black 2010: 2 g/day reduced eccentric-exercise muscle pain ~25%). Effects appear strongest with 1-2 weeks of pre-exercise loading.
10 high-quality clinical trials evaluating ginger supplementation for hyperemesis gravidarum (severe pregnancy nausea).
Clinical population described in trial publication.
10 high-quality clinical trials evaluating ginger supplementation for hyperemesis gravidarum (severe pregnancy nausea). Ginger comparable to vitamin B6 and metoclopramide for symptom relief in mild-to-moderate HG, with favorable safety profile. Severe HG generally still requires conventional antiemetic therapy.